# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016149
Filing Date
2022-11-03
Accepted
2022-11-03 08:00:53
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ewtx-20220930x10q.htm iXBRL | 10-Q | 2151825
2 | EX-31.1 | ewtx-20220930xex31d1.htm | EX-31.1 | 16969
3 | EX-31.2 | ewtx-20220930xex31d2.htm | EX-31.2 | 17243
4 | EX-32.1 | ewtx-20220930xex32d1.htm | EX-32.1 | 7540
5 | EX-32.2 | ewtx-20220930xex32d2.htm | EX-32.2 | 7617
| Complete submission text file | 0001558370-22-016149.txt |  | 6624951

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | EX-101.SCH | ewtx-20220930.xsd | EX-101.SCH | 35681
7 | EX-101.CAL | ewtx-20220930_cal.xml | EX-101.CAL | 41602
8 | EX-101.DEF | ewtx-20220930_def.xml | EX-101.DEF | 158776
9 | EX-101.LAB | ewtx-20220930_lab.xml | EX-101.LAB | 364555
10 | EX-101.PRE | ewtx-20220930_pre.xml | EX-101.PRE | 277913
52 | EXTRACTED XBRL INSTANCE DOCUMENT | ewtx-20220930x10q_htm.xml | XML | 964785

Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40236 | Film No.: 221356322
SIC: 2834 Pharmaceutical Preparations